{"DataElement":{"publicId":"2591947","version":"2","preferredName":"Positron Emission Tomography Diagnostic Imaging Assessment Ind-2","preferredDefinition":"the yes/no indicator related to an assessment or evaluation using Positron Emission Tomography, a computerized image of the metabolic activity of body tissues used to determine the presence of disease.","longName":"PET_DXIM_ASSESS_IND2","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2603748","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging Assessment","preferredDefinition":"information related to a diagnostic assessment or evaluation using Positron Emission Tomography, a computerized image of the metabolic activity of body tissues used to determine the presence of disease.","longName":"PET_DXIMG_ASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2603746","version":"1","preferredName":"Positron Emission Tomography Diagnostic Imaging","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.:Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation..","longName":"C17007:C16502","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnostic Imaging","conceptCode":"C16502","definition":"Any method that uses a visual display of structural or functional patterns of organs or tissues for diagnostic evaluation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7BF69C-E28A-5DAD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"ONEDATA","dateModified":"2007-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2261670","version":"1","preferredName":"Assessment","preferredDefinition":"Examination of the body by auscultation, palpation, percussion, inspection, and olfaction.  (Taber's)","longName":"C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2590-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-11","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-11","modifiedBy":"ONEDATA","dateModified":"2005-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7BF70A-994D-5E06-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2670694","version":"1","longName":"Disease Relapse","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2812926","version":"1","longName":"Lymphoma Relapse","context":"NHLBI"},{"publicId":"2812928","version":"1","longName":"Solid Tumor Relapse","context":"NHLBI"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964911","version":"1","longName":"2118r1: Lymphoma Post-HSCT Data","context":"NHLBI"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"PET_DXIM_ASSESS_IND2","type":"USED_BY","context":"CTEP"},{"name":"LYMpre_dis_assess_prep_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpost_best_resp_stat_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"LYMpost_rel_progress_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_nodal_organ_inv_diag_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"NHLBI","type":"USED_BY","context":"NHLBI"},{"name":"LYMpre_nodal_organ_invol_trans_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"Alliance","type":"USED_BY","context":"Alliance"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"TDIS_LYM_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_noid_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_noit_pet_scan_yn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Was FDG-PET Scan performed","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Was a FDG-PET scan done to evaluate MIBG non-avid disease sites","url":null,"context":"CTEP"},{"name":"Was PET scan done","type":"Preferred Question Text","description":"Was PET scan done","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"PET Scan","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"PET staging","url":null,"context":"CTEP"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"Was FDG-PET scan done if MIBG non-avid disease present?","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_4","type":"Alternate Question Text","description":"Was FDG-PET scan performed during this reporting period?","url":null,"context":"CTEP"},{"name":"Was a PET (or PET/CT) scan performed?","type":"Application Standard Question Text","description":"Was a PET (or PET/CT) scan performed?","url":null,"context":"NHLBI"},{"name":"Was a PET scan performed?","type":"Alternate Question Text","description":"Was a PET scan performed?","url":null,"context":"NHLBI"},{"name":"COG CRF TEXT 7","type":"Alternate Question Text","description":"Was a PET scan of the primary site performed at baseline?","url":null,"context":"COG"},{"name":"COG CRF TEXT 6","type":"Alternate Question Text","description":"Was a PET scan of the primary site done?","url":null,"context":"COG"},{"name":"COG CRF TEXT 5","type":"Alternate Question Text","description":"Was an FDG-PET scan obtained during this reporting period?","url":null,"context":"COG"},{"name":"COG CRF Text 9","type":"Alternate Question Text","description":"Was a response assessed for PET2?","url":null,"context":"CTEP"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"Was FDG-PET done at baseline?","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"PET scan","url":null,"context":"Alliance"},{"name":"NRG Text 1","type":"Alternate Question Text","description":"Does the baseline F-FDG-PET/CT identify hypermetabolic para-aortic disease?","url":null,"context":"NRG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"Was baseline FDG-PET scan performed?","url":null,"context":"COG"},{"name":"Was a PET (or PET/CT) scan performed?","type":"Alternate Question Text","description":"Was a PET (or PET/CT) scan performed?","url":null,"context":"NHLBI"},{"name":"Was a PET/CT scan performed?","type":"Alternate Question Text","description":"Was a PET/CT scan performed?","url":null,"context":"NHLBI"},{"name":"Was a PET / CT scan performed during this reporting period?","type":"Alternate Question Text","description":"Was a PET / CT scan performed during this reporting period?","url":null,"context":"NHLBI"},{"name":"COG CRF Text 11","type":"Alternate Question Text","description":"Did the patient have a whole body or limited whole body PET scan performed within 42 days prior to enrollment?","url":null,"context":"COG"}],"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C521FD4A-2136-FC5E-E040-BB89AD43363B","latestVersionIndicator":"Yes","beginDate":"2012-07-18","endDate":null,"createdBy":"DWARZEL","dateCreated":"2012-07-18","modifiedBy":"KUMMEROA","dateModified":"2023-03-17","changeDescription":"12/29/15 added alt question for Sarah Brett/NRG. jk  Replaced VD Assessments Ind-2 2018320v1.0 with VD ID#3506068 - Yes No Indicator, set wfs \"Released\", effective begin date 7/18/2012, created whole number version - dbw","administrativeNotes":"2023.3.17 AQT added per ticket request CADSR0002164. ak","unresolvedIssues":null,"deletedIndicator":"No"}}